ADENOID CYSTIC CARCINOMA
Clinical trials for ADENOID CYSTIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADENOID CYSTIC CARCINOMA trials appear
Sign up with your email to follow new studies for ADENOID CYSTIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested a new drug called felmetatug vedotin, alone or with pembrolizumab, in people with advanced solid tumors (like ovarian, breast, lung, and others). The goal was to check safety and find the right dose. The trial was terminated early, so results are limited.
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated May 17, 2026 02:07 UTC
-
Rare cancer imaging study halted after enrolling just one person
Knowledge-focused TerminatedThis study aimed to see if a radioactive tracer (177Lu-PSMA) could help measure radiation doses in tumors for people with a rare salivary gland cancer called adenoid cystic carcinoma that had spread or come back. Only one person enrolled before the study was stopped early. The ma…
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Knowledge-focused
Last updated May 17, 2026 02:04 UTC